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Background aims. Mesenchymal stromal cells (MSCs) are regenerative and immuno-privileged cells that are used for both tissue
regeneration and treatment of severe inﬂammation-relateddisease. For quality control ofmanufacturedMSCbatches in regard to
mature fat cell contamination, a quantitative method for measuring adipogenesis is needed. Methods. Four previously proposed
methods were validated with the use of bone marrow (BM) MSCs during a 21-day in vitro assay. Oil red staining was scored
semiquantitatively; peroxisome proliferator activated receptor-g and fatty acid binding protein (FABP)4 transcripts were
measured by quantitative real-time polymerase chain reaction; FABP4 protein accumulation was evaluated by ﬂow cytometry;
and Nile red/40,6-diamidino-2-phenylindole (DAPI) ratios were measured in ﬂuorescent microplate assay. Skin ﬁbroblasts and
MSCs from fat pad, cartilage and umbilical cord were used as controls. Results. Oil red staining indicated considerable
heterogeneity between BM donors and individual cells within the same culture. FABP4 transcript levels increased 100- to
5000-fold by day 21, with large donor variability observed. Flow cytometry revealed increasing intra-culture heterogeneity over
time; more granular cells accumulated more FABP4 protein and Nile red ﬂuorescence compared with less granular cells. Nile
red increase in day-21 MSCs was w5- and 4-fold, measured by ﬂow cytometry or microplate assay, respectively. MSC
proliferation/apoptosis was accounted through the use of Nile red/DAPI ratios; adipogenesis levels in day-21 BM MSCs
increasedw13-fold, with signiﬁcant correlations with oil red scoring observed for MSC from other sources. Conclusions. Flow
cytometry permits the study of MSC differentiation at the single-cell level and sorting more and less mature cells from mixed
cell populations. The microplate assay with the use of the Nile red/DAPI ratio provides rapid quantitative measurements and
could be used as a low-cost, high-throughput method to quality-control MSC batches from different tissue sources.
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The capacity of multipotential stromal cells (MSCs) to
differentiate into a range of cell types including chon-
drocytes, tenocytes, adipocytes and osteoblasts is well
established (1e3). Typically, MSCs are isolated from
bonemarrow (BM) aspirates taken from the iliac crest.
Although MSCs represent only a small fraction
of nucleated cells in the BM aspirates (between
0.001e0.01%), they can expanded with high efﬁciency
(3e5), representing a rapidly expandable, easy to access
source of multipotent cells to treat a wide variety of
conditions through tissue engineering and cell therapy.
Another feature that makes MSCs desirable for use in
regenerative medicine is the reported immunoprivi-
leged nature of these cells and their ability to reduce
inﬂammation and exhibit immunosuppressive effectsCorrespondence: Dr Elena Jones, Academic Unit of Musculoskeletal Disease, Le
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regenerativemedicine applications (9,10).Much of the
research in the immunological properties of MSCs,
however, has been carried out on undifferentiated
MSCs, and although there are some reports on
immune-marker expression on MSCs after short-term
differentiation toward bone, fat or cartilage tissue (11),
little is known with respect to the immunological
properties of MSCs after longer-term differentiation,
including longer-termadipogenicdifferentiation for the
therapeutic applications aimed at plastic and recon-
structive surgery.
The differentiation of MSCs into adipocytes
presents an interesting system for the study of their
post-differentiation immunological properties.Mature
adipose cells have been shown to secrete hormoneseds Institute of Molecular Medicine, Room 5.24 Clinical Sciences Building,
ublished by Elsevier Inc. All rights reserved.
90 A. Aldridge et al.termed “adipokines,” such as leptin, resistin and adi-
ponectin (12). These adipokines are known to exert
potent immunomodulatory effects on cells of the
immune system (12,13). At the same time, adipocytes
produce pro-inﬂammatory cytokines (tumor necrosis
factor-a and interleukin-6) and chemokines such
as monocyte chemoattractant protein-1 (MCP)-1
(12,14). Contamination of therapeutic MSC batches
with preadipocytes and adipocytes, particularly those
derived from lipoaspirates, may therefore pose addi-
tional safety considerations in the treatment of Crohn
disease (15,16) and in reconstructive surgery (17).
To study the immunological properties of MSCs
during the process of adipogenic differentiation in
vitro and after implantation in vivo, a robustmethod to
quantify the achieved level of adipogenesis is required.
Various methods have been used previously to
evaluate MSC adipogenesis, such as quantitative
real-time polymerase chain reaction (q-PCR) for adi-
pogenesis-related transcripts (18e22),ﬂow cytometry
(18,20,23,24), oil red O staining (3,4,19,25,26) and
Nile red staining (18,20,23,27). However, a compar-
ative evaluation of these differentmethodswith the use
of MSCs from the same donors has not yet been per-
formed. The aim of this study was to directly compare
these methods to (i) establish the most robust method
for measuring the extent of adipogenesis achieved and
(ii) evaluate cell-to-cell heterogeneity within the same
MSC batch, thus allowing evaluation of direct effects
of MSC adipogenic commitment on their immuno-
regulatory properties.
Methods
Isolation and expansion of MSCs and control skin
ﬁbroblasts
Unless otherwise stated,MSCs used in this studywere
isolated fromBMaspirates. HumanBMwas obtained
from the iliac crest of four healthy donors (median age,
24; range, 8e69 years), and MSC cultures were
established according to Pittenger et al. (3). Brieﬂy,
mononuclear cells (MNCs) were isolated from BM
through the use of Lymphoprep (Nycomed Pharma,
Oslo, Norway), and plastic-adherent cells were grown
in NH Expansion medium (Miltenyi Biotech, Surrey,
UK) in 25-cm2 tissue culture ﬂasks (Corning, Flint-
shire, UK) at 37C 5% (v/v) CO2 in air to passage 2
(p2). In addition, MSCs were grown from knee
cartilage and fat pads of patients with osteoarthritis
(n¼3;median age, 72.5 years; range, 69e77 years), as
described previously (25), or from umbilical cord
tissue (n ¼ 3), according to methods described by
Majore et al. (28) and Karahuseyinoglu et al. (29).
Human skin ﬁbroblasts were obtained from the
American Type Culture Collection (ATCC) (Ted-
dington, UK) and were expanded in completeDulbecco modiﬁed Eagle’s medium (DMEM, Invi-
trogen, Paisley, UK) with 10% fetal calf serum (FCS),
50 U.mL1 penicillin/streptomycin and 2 mmol/L
L-glutamine (all from Sigma, Poole, UK). Ethical
permission to use human tissue samples was obtained
from Leeds Teaching Hospitals NHS Trust.Adipogenic differentiation of MSCs and ﬁbroblasts
Adipogenic medium was made by supplementing
complete DMEM with 10% v/v FCS, 10% v/v
horse serum (Stem Cell Technologies, Shefﬁeld,
UK), 0.5 mmol/L isobutylmethylxanthine (IBMX),
0.06 mmol/L indomethacin, 50 pmol/L hydrocorti-
sone, 2 mmol/L L-glutamine (all from Sigma) and
antibiotics, as previously described (3,4,11,30). Adi-
pogenic differentiation assays were performed in 24-
and 48-well plates, with the use of constant cell seeding
density of 4  104 cells per cm2. Adipogenic medium
was changed twice weekly (one-half media changes)
during a 21-day time course, and samples were taken
for analysis at different time points as speciﬁed below.Oil red staining for semiquantitative scoring of
adipogenesis
Before staining, cells were washed twice with PBS and
ﬁxed in 10% (v/v) formalin (Biostain Ready Reagents,
Manchester, UK). After ﬁxation and two further
washes in PBS, oil red solution [0.5% oil red (w/v)
(Sigma) in isopropanol] was added for 10 min. After
incubation at room temperature (RT), oil red was
removed, and cells were washed twice in PBS and
stained with Harris hematoxylin (Surgipath, Bretton,
UK) for 45 seconds. Subsequently, cells were washed
in tap water and allowed to dry before viewing.
The amount of fat in individual cells was scored
semiquantitatively through the use of a grading scheme
developed by English et al. (25). The level of adipo-
genesis was described by ranking 500 cells in a middle
area of the well on their fat content. Ranks were allo-
cated on the basis of the proportion of cytoplasm
occupied by fat globules: grade 1: 0e24%; grade 2:
25e49%; grade 3: 50e74%; grade 4: 75e100%
(Figure 1A). Subsequently, a relative percentage of
cells assigned to each grade was calculated for triplicate
wells and averaged.Quantitative real-time PCR for peroxisome proliferator
activated receptor-g and fatty acid binding protein 4 gene
expression
Peroxisome proliferator activated receptor (PPAR)-g
andparticularly fatty acidbindingprotein (FABP)4 (31)
have been previously used as common molecular
markers of MSC adipogenesis (18,20,22). RNA was
Figure 1. Semiquantitative scoring of adipogenesis with the use of
oil red. (A) Visual grading scheme on the basis of lipid droplet
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with the use of Superscript II reverse transcriptase
(Invitrogen). Q-PCR was performed with the use of an
ABPrism7900HTsequencedetection system (Applied
Biosystems,Warrington,UK) in thepresenceofSYBR-
green. Primers were designed with the use of Primer
Express 2 (Applied Biosystems) and supplied byMWG
Biotech (Ebersberg, Germany). Expression was nor-
malized through the use of the reference geneGAPDH.
PrimerconcentrationsusedwerePPAR-gF;cacaagaac
aga tcc agt ggt tg (500 nmol/L), PPAR-g R; gag gct tat
tga gag ctg agt ctt ct (500nmol/L), FABP4F; cca taa aga
gaa aac gag agg atg at (1000 nmol/L), FABP4R; tgg aag
tga cgc ctt tca tga (1000 nmol/L), GAPDH F; aac agc
gac acc cac tcc tc (500 nmol/L), GAPDHR; cat acc agg
aaa tga gct tga caa (500 nmol/L); all primer pairs were
tested and found to be equally efﬁcient. MSCs from
three different donors were used, and for each time
point the mean Ct of three technical replicates of each
gene of interest was used to calculate the relative gene
expression.Flow cytometry for FABP4 and Nile red staining
ForNile red staining, cells were harvested by treatment
with 0.5% trypsin/EDTA (Invitrogen), washed in PBS
and ﬁxed with 10% (v/v) formalin in PBS. Stock Nile
red (Sigma) solution (0.1 mg.mL1, prepared in
methanol) was added to cells at a ﬁnal concentration of
0.05 mg mL1 (1:2000 dilution in PBS) (17) and
incubated at 4C for 20 min. Cells were washed in BD
FACSﬂow before ﬂow cytometry was carried out with
the use of a FACScan. Nile red ﬂuorescence emission
in adipogenically differentiatedMSCs was detected on
FL2 channel (bandpass ﬁlter, 585  42 nm).
FABP4 protein was detected with the use of a puri-
ﬁedpolyclonal goat anti-humanFABP4antibody (IgG,
R & D Systems, Abingdon, UK) at 1:20 dilution in
PBS. For intracellular staining with FABP4, trypsi-
nized cells were initially ﬁxed in 100 mL of Intrastain
reagent A (Dako, Cambridge, UK). FABP4 antibody
was added together with 100 mL of permeabilizing
reagent/Intrastain reagentB (Dako) for 15min atRT in
the dark. After two washes with PBS, cells were incu-
bated with biotinilated rabbit anti-goat secondaryaccumulation: microphotographs of representative cells assigned
to grades 1e4. Grades represent the proportion of cell cytoplasm
occupied by lipid droplets. (B) Adipogenesis time course: ﬁbro-
blasts (left panels) and BM MSCs (right panels) were differenti-
ated over 21 days into fat lineage, and microphotographs were
taken from a central area of a representative triplicate well. (C)
Percentage of grade 1 cells. (D) Percentage of cells of grades 2 and
above. BM1-3 represents the three different donors, and the
percentage shown is the mean value from triplicate wells for each
donor. X-axis numbers represent days of culture. Original
magniﬁcations: 400 for A and 100 for B.
92 A. Aldridge et al.antibody (1:400 dilution in PBS, Dako) for 15 min at
RT in the dark. After two more washes in PBS, the
binding was visualized with the use of streptavidin-
FITC (1:50 dilution, BD Sciences). After two ﬁnal
washes, the ﬂuorescence was analyzed on FL1 channel
(bandpass ﬁlter, 530  30 nm), with 10000 events
being collected in each sample.Flow cytometry for MSC marker expression
The following antibodies were used to test MSC
marker expression on undifferentiated and day-16
adipogenically differentiated BM MSCs (n ¼ 2) and
skin ﬁbroblasts (n ¼ 1): CD73-PE, CD90-PE,
CD166-PE, CD44-PE (all from BD, Oxford, UK),
CD105-PE, CD13-FITC, CD31-FITC (all from
Serotec, Kidlington, UK) and CD45-FITC (Dako,
Ely, UK). All isotype controls were from Serotec,
and extended phenotyping of polyclonal and clonal
cultures was performed as previously described (32).Measure of adipogenic differentiation using Nile red/40,6-
diamidino-2-phenylindole (DAPI) staining
MSCs and ﬁbroblasts were seeded in a 48-well plate
(Nunc, Loughborough, UK) and cultured for 21 days
in adipogenic medium. On days 0, 3, 7, 14 and 21,
the level of adipogenesis was determined with the use
of a luminescent plate reader (LB940 Multilabel
Reader Mithras; Berthold Technologies), with each
condition having six replicates. At each time point, the
medium was removed; wells were washed twice with
PBS and ﬁxed with 200 mL of formalin (10% v/v in
PBS) for 30 min at RT. Subsequently, wells were
washed twice with PBS and the background ﬂuores-
cence was read in 200 mL of PBS with the use of
DAPI (355/460) and Nile red (485/540) ﬁlter sets as
per the manufacturer’s instructions (27,33). These
ﬁlter sets were used because they provided the closest
match to DAPI (excitation at 358 nm and emission at
461 nm) and Nile red (excitation at 450e500 nm and
emission at >528 nm) (23,33).
Wells were spot-read in a 10 10 pattern per well.
After background reading, the PBS was removed and
200 mL of saponin (Sigma, Poole, Dorset, UK) (0.2%
w/v in PBS) was added along with DAPI (Invitrogen)
at a ﬁnal concentration of 1 mg.mL1 and Nile red at
a ﬁnal concentration of 1 mg.mL1 (33). The plate was
then wrapped in foil and incubated at RT for
15 minutes. After three washes with PBS, 200 mL of
PBS was added and plates were again read as above.
To calculate the Nile red:DAPI ratio, the back-
ground ﬂuorescence was ﬁrst subtracted from the
readings. The mean ﬂuorescent reading for six
replicates was calculated for both Nile red and
DAPI; Nile red:DAPI ratio was then established andnormalized to day 0 (undifferentiated cells). Fluo-
rescent microscopy images were taken with an
Olympus IX71 inverted microscope using Cell
ˇ
B
image capture software (Olympus).Statistical analysis
To determine whether the methods used for
measuring adipogenic progression were comparable,
R values and two-tailed P values were calculated by
means of Spearman correlation in Graphpad Prism
5. Standard deviations were also calculated by means
of Graphpad Prism 5.Results
Semiquantitative scoring of adipogenesis of MSCs with
the use of oil red staining
The most common staining for adipogenically
differentiated MSCs (oil red staining) was initially
used and quantiﬁed by means of a visual grading
system (25) whereby the level of adipogenic
progression in 500 cells in a central area of the well
was ranked from 1e4 on the basis of the proportion
of cytoplasm occupied by fat in each cell (Figure 1A).
Subsequently, a relative percentage of cells assigned
to each grade was calculated for triplicate wells and
averaged. In these experiments, MSCs from three
BM donors and negative control skin ﬁbroblasts
were grown in adipogenic medium for 21 days
(Figure 1B), and scoring was performed on days 0, 3,
7, 14 and 21 after induction (Figure 1BeD).
As seen in Figure 1C, ﬁbroblasts gradually
accrued grade 1 levels of fat content; however, they
were unable to progress to higher grades in fat
accumulation (Figure 1D). In all MSCs, differenti-
ation had begun as a gradual accumulation of grade 1
cells (Figure 1C). In contrast to ﬁbroblasts, however,
MSCs continued to amass fat in their cytoplasm and
by days 14e21 contained cells with high fat content
(grades 2e4, Figure 1D).
These experiments showed that although ﬁbro-
blasts were clearly inferior to MSCs, they had some
capacity for adipogenesis. Furthermore, adipogenic
progression in MSCs from the same donor was
heterogeneous, with some cells in the cultures pro-
gressing to grades 3e4 and others remaining at grade 1.
Finally, donor-to-donor differences in the rates and the
amounts of adipogenesis in MSCs were also observed,
with BM1 being more “resistant” to adipogenesis,
compared with the other two donors (the latter easily
progressed to grades 3e4). Altogether, these data
showed that more quantitative methods of measuring
adipogenesis are needed to account for these
differences.
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(m)RNA expression in MSCs undergoing adipogenesis
Adipogenesis-speciﬁc PPAR-g and the late marker of
adipogenesis, FABP4, have been previously shown to
closely reﬂect adipogenic progression of MSCs
(18,20,22,34). PPAR-g and FABP4 mRNA levels
were next determined in adipogenically differenti-
ated MSCs and correlated to morphological fat
accumulation within the cells. When normalized to
GAPDH, donor-to-donor differences in PPAR-g
expression levels in MSCs on day 0 were consider-
able (7-fold); therefore relative gene expression data
for days 3, 7, 14 and 21 after induction were further
normalized to their baseline levels in undifferentiated
cells (day 0) (Figure 2).
In ﬁbroblasts, PPAR-g gene expression increased
gradually to approximately 30-fold on day 21. PPAR-
g gene expression in MSCs increased gradually
to approximately the same levels, with greater donor
variability observed at earlier time points (Figure 2A).
FABP4 gene expression in ﬁbroblasts mirroredFigure 2. Monitoring adipogenic progression of MSCs and
ﬁbroblasts with the use of q-PCR. MSCs and ﬁbroblasts were
cultured in adipogenic medium for 21 days. Expression of (A)
PPAR-g and (B) FABP4 was determined on days 0, 3, 7, 14 and
21. Relative levels of gene expression were normalized to reference
gene GAPDH and displayed as fold increase over day 0. Each data
point represents the mean of three replicates.that of PPAR-g (Figure 2B). FABP4 gene expression
in MSCs was above that of ﬁbroblasts at all time
points and increased by 2e3 orders of magnitude by
day 21.Monitoring FABP4 protein accumulation and its
correlation with Nile red staining by ﬂow cytometry
FABP4 has been documented as one of the best
markers of adipogenesis measured by q-PCR (31);
however, FABP4 protein accumulation in adipo-
genically drivenMSCs by ﬂow cytometry has not been
reported and was next investigated (Figure 3A).
First, ﬂow cytometry has revealed some interesting
changes in MSC scatter characteristics as a result of
their differentiation towards the adipogenic lineage.
At the later stages of differentiation, an accumulation
of more granular cells (high side scatter [SSC],
possibly reﬂecting fat globuli) was observed. As ex-
pected, FABP4 protein gradually accumulated in
MSCs, and its levels were always higher in more
granular cells (high-SSC) comparedwith less granular
cells (low-SSC) (Figure 3A). Differences in granu-
larity/SSC were, however, too small (<2-fold by day
14) to be considered as a robust measure of adipo-
genesis (Figure 3B). Furthermore, a drop in the
proportion of high-SSC cells by day 21 was observed
(Figure 3B) and could be explained by their loss
during centrifugation steps because they were ex-
pected to be more buoyant.
The mean level of FABP4 protein accumulation in
MSCs on day 21 was 6-fold stronger compared with
day 0. These data clearly conﬁrmed the existence of
cell-to-cell heterogeneity within the same adipogeni-
cally driven MSC culture, ﬁrst observed by morpho-
logical analysis with oil red. Flow cytometry for
FABP4þ cells and semiquantitative scoring with
oil red displayed excellent correlation (r ¼ 0.989,
P  0.0001).
FABP4 staining for ﬂow cytometry requires cell
permeabilization and multiple centrifugation steps;
therefore a simple cytometric method of staining with
Nile red, a dye that binds to intracellular lipids, was
next attempted (23,35e37). Similar trends were
observed when Nile red staining was used instead of
FABP4 (Figure 3C). Nile red accumulation in low-
SSC cells and high-SSC cells increased in parallel
(Figure 3D). The average overall Nile red content in
MSCs on day 21 was 5-fold stronger compared with
day 0. With the use of the same donor samples, Nile
red dye and intracellular FABP4 antibody labeling
demonstrated excellent correlation (r ¼ 0.958, P <
0.0001). Nile redebased ﬂow cytometry also showed
good correlation with morphological scoring by oil
red (r ¼ 0.952, P < 0.0001) for all donors and all
time points tested.
Figure 3. Monitoring adipogenic progression of MSCs with the use of ﬂow cytometry for FABP4 and Nile red. (A) Representative histogram
plots for FABP4 staining. (B) The increase in SSC characteristics for the whole population of cells as the time course progresses; error bars
represent standard deviation of the mean for three donors tested. (C) Representative histogram plots for Nile red staining. (D) Nile red
ﬂuorescence of both populations of gated low- and high-SSC cells, demonstrating a parallel increase throughout the time course. Days 0 and
3 are omitted because of very low frequency of high-SSC early in differentiation. Numbers in the top right corners of histograms represent
median ﬂuorescence intensities. FI is ﬂuorescent intensity.
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Nile redþ cells was observed during adipogenic
differentiation of ﬁbroblasts (data not shown). The
expression of several MSC surface markers (CD73,CD105, CD90, CD44, CD166, CD13) and non-
MSC controls [CD45, CD31 (38)] was next inves-
tigated on day-16 adipogenic MSC cultures and
ﬁbroblasts and compared with their baseline levels
Figure 4. Nile red and DAPI staining of MSCs. MSCs and ﬁbroblasts were grown for 0, 3, 7, 14 and 21 days in adipogenic medium and
stained with Nile red dye and DAPI. Representative images of (A) ﬁbroblasts and (B) MSCs on day 21 are shown. Intracellular lipid droplets
in cells stain yellow/gold, and the nucleus is stained blue. Images shown are 200 magniﬁcation. (C) Levels of ﬂuorescence for DAPI and
Nile red were measured for ﬁbroblasts cultured in adipogenic medium. Error bars shown are  standard deviation (deviation between
replicate wells). (D) Levels of ﬂuorescence for DAPI and Nile red were calculated for BM MSCs 1e4 cultured in adipogenic medium, and
the mean values normalized to day 0 shown. Error bars shown are  standard deviation (deviation between donors). (E) Adipogenesis of
MSCs isolated from umbilical cord (UC), knee cartilage (C), knee fat pad (FP) and bone marrow (BM) on day 21 of culture. Error bars
shown are  standard deviation (n ¼ 3 donors each). (E) Correlation between Nile red/DAPI ratios and grades 2þ3þ4 semiquantitative
scoring. These methods exhibited signiﬁcant levels of correlation (r ¼ 0.983, P < 0.0001).
Assay validation for assessment of adipogenesis of multipotential stromal cells 95in undifferentiated cells. No signiﬁcant differences
in the expression of any markers were found be-
tween MSCs and ﬁbroblasts before differentiation
(CD73þCD105þCD90þCD44þCD166þCD13þCD
45CD31), consistent with previous reports (39), as
well as between day-0 and day-16 MSCs, indicating
the lack of surface marker selectivity for adipogeni-
cally differentiated cells (data not shown).Quantiﬁcation of MSC adipogenic progression with the
use of microplate assay with Nile red and DAPI
A Nile redebased ﬂuorescence microplate assay
was next evaluated for its suitability to measureadipogenesis, with DAPI staining for DNA used to
account for cell proliferation/apoptosis (27,33). MSCs
or ﬁbroblasts were cultured in adipogenic medium in
wells of a 48-well plate; DAPI and Nile red readings
were taken on days 0, 3, 7, 14 and 21 after induction.
Representative ﬂuorescence microscopy images of
ﬁbroblasts andMSCs on day 21 are shown (Figure 4A
and 4B, respectively).
To determine whether adipogenesis could be
measured using Nile red only, levels of ﬂuorescence
for DAPI alone and Nile red alone were ﬁrst
measured. Initially, levels of DAPI staining decreased
before a gradual increase in ﬁbroblasts (suggesting
initial apoptosis before recovery and proliferation) but
96 A. Aldridge et al.ﬂuctuated in MSCs after day 3 (Figure 4C,D). Nile
red staining in ﬁbroblasts remained low (Figure 4C)
and, not surprisingly, showed a greater increase in
MSCs (Figure 4D). The differences in Nile red
accumulation inMSCs were on average 3-fold (day 7/
day 0 ratio) and 4-fold (day 21/day 0 ratio).
Nile red ﬂuorescence in MSCs was next nor-
malized to DAPI staining to account for MSC
proliferation/apoptosis, and a ratio of Nile red/DAPI
was used to measure adipogenesis. Nile red to DAPI
ratios demonstrated minimal adipogenesis in ﬁbro-
blasts (Figure 4C) but an increase in adipogenesis in
MSCs (Figure 4D). The differences in Nile red/
DAPI ratios in MSCs were on average 7-fold (day 7/
day 0 ratio) and 13-fold (day 21/day 0 ratio).
Both Nile red microplate assays and morpho-
logical scoring with oil red signiﬁcantly correlated
with each other for all donors and all time points
tested (r ¼ 0.931, P  0.0001). We ﬁnally evaluated
congruency between these two assays through the
use of MSCs derived from a highly adipogenic tissue
[knee fat pad (25,40)] and poorly adipogenic tissues
[knee cartilage (25) and umbilical cord (41e43)].
Consistent with observations obtained using oil red
staining (25), the results for Nile red/DAPI ratios
showed that knee fat pad MSCs had higher levels of
adipogenesis compared with cartilage or umbilical
cordederived MSCs (Figure 4E). Regardless of the
MSC tissue source used, the correlation between the
oil red and Nile red assays was very good (r ¼ 0.983,
P < 0.0001) (Figure 4F).Discussion
There are currently more than 120 MSC-based clin-
ical trials aimed to treat a number of human diseases
including immune-related and auto-immune diseases
as well as severe myocardial ischemia, bone defects,
osteoarthritis or liver disease (clinicaltrials.gov).More
recently, adipose tissueederived MSC sources have
become popular because of ease of access and har-
vesting of this tissue (more than 40 trials). Further-
more, the stromal vascular fraction (SVF) from
lipoaspirates without the MSC isolation by culture
ampliﬁcation has attracted increased interest as
a therapeutic product, presumably because of its low
cost and ease of manufacture (44,45). However,
concerns may exist relating to purity of these prepa-
rations and possible contamination with maturing fat
lineage cells that can potentially be immunogenic
(13,14,46). This necessitates the development of new
tools to control the quality of manufacturedMSC and
SVF batches with respect to the presence of contam-
inating fat lineage cells at different stages of matura-
tion and the assessment of their contribution to
clinical outcomes after implantation. In addition toassaying for fat cell contamination, another viable
application of adipogenic cell assays is the prediction
of the development of undesirable cell phenotypes.
With the increasing number of commercial products
based on allogeneic MSCs, preliminary screening of
MSC multipotentiality and adipogenic propensity in
particular could be used to negatively select against
the most adipogenic MSC donors.
With these considerations in mind, the aim of this
study was to compare previously proposed indepen-
dent methods for measuring MSC adipogenesis and
to develop a reliable assay with well-deﬁned in vitro
conditions. In the present study, we report both
advantages and disadvantages of the four methods
tested (Table I) and particularly highlight (i) the
utility of ﬂow cytometry for dissecting cell-to-cell
heterogeneity within the same differentiating culture,
with a potential to sort less and more differentiated
subpopulations and (ii) the advantage of a Nile
redebased microplate assay to provide rapid
measurements of both MSC adipogenesis and
proliferation/apoptosis in differentiating adipogenic
cultures.
Oil red dye is a member of the Sudan lysochrome
family of dyes and has been used for more than
50 years as a stain for neutral triglycerides, phos-
pholipids and cholesterol esters (47). Many studies
used oil red to measure adipogenesis but made no
attempt to quantify levels (3,48,49). Zimmerlin et al.
(26) used a system that counted cells with at least ﬁve
large oil red vesicles under low-power ﬁeld micros-
copy (10 objective and ﬁve to eight ﬁelds).
Other studies quantiﬁed adipogenesis by re-
moving oil red from within the lipid vesicles with
isopropanol and measuring the absorbance at 510
nm (50). The latter method, however, does not give
any indication as to cell number or average levels of
lipid per cell; in addition, the absorbance of samples
is subject to variation caused by the degradation of
isopropanol over time (isopropanol is a volatile
organic solvent). Another method, the assessment of
triglyceride content, can be performed after extrac-
tion of triglyceride from the cell by DMSO and then
quantiﬁcation through the use of enzyme-based kits
and absorbance measurements (51). This method
also has some of the same issues that extracting oil
red from stained cells with isopropanol has in that it
is difﬁcult to determine cell number or average levels
of lipid per cell.
In our experiments, we noted that not all cells
within the same adipogenic culture differentiated at
the same rate, which could be due to differing levels of
pre-commitment between seeded MSCs in different
donors and/or cell density, as suggested previously
(22). Additionally, large donor-to-donor variability
was observed with all assays used. Other studies have
Table I. Advantages and disadvantages of different assays for the evaluation of MSC adipogenesis.
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Flow cytometry with Nile
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Flow cytometry: 1 h plus
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by FACS and its
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and heterogeneous nature of MSC populations
derived from BM (52) or adipose tissue (53).
For q-PCR, two genes associated with adipo-
genesis were selected: PPAR-g and the late marker
of adipogenesis, FABP4. Both of these transcripts
have been shown to increase in adipogenesis.
PPAR-g is a nuclear receptor, which, on stimula-
tion with ligand, binds to retinoid-X receptor, and
this complex can bind to DNA and initiate tran-
scription (21). The exact factors involved in
differentiation into mature adipocytes are not
currently fully understood, but many different
genes have been reported to be involved. These
genes include CAAT/enhancer binding protein-
a (C/EBPa), FABP4, insulin-like growth factor
binding protein 2 (IGFBP2), resistin, adiponectin
and lipoprotein lipase, which simulates fatty acid
binding and sequestering in mature adipocytes
(22,54,56). FABP4 was chosen as the most selected
late marker of adipogenesis (22); it is also known as
fatty acid binding protein (aP2) in other mammals
and is involved in the metabolism and intracellular
transport of fatty acids in adipose cells. It is able to
bind the fatty acids with a high afﬁnity and reloc-
alize them to other parts of the cell (57) including to
lipid droplets for storage, the endoplasmic retic-
ulum for signaling, the mitochondria or peroxisome
for oxidation and to the nucleus for the control of
lipid-mediated transcriptional programs via nuclear
hormone receptors, or other transcription factors
that respond to lipids (58).
In contrast to PPAR-g expression, which, under
our experimental conditions, displayed only small
changes, FABP4 expression increased by 2e3 orders
of magnitude by the end of differentiation time
course. Sole measurement of PPAR-g expression by
q-PCR was unlikely to be sufﬁcient to monitor adi-
pogenic progression in MSCs, whereas FABP4
expression increased most dramatically, consistent
with previous ﬁndings (31), and correlated very well
with microscopic fat accumulation in MSCs (r ¼
0.989, P < 0.0001). Our ﬁndings correlate well with
the study of Boucher et al. (31). These investigators
used a q-PCR assay to routinely characterize MSC
differentiation into adipocytes, mainly for media
potency evaluation, shortening the length of time
required to 7 days. In their study, FABP4 upregula-
tion was observed as early as day 3 after induction,
with expression persisting throughout longer periods
of differentiation, in agreement with our ﬁndings.
Studies in cultures of adipose-derived MSCs have
reported similar patterns of expression, in which
PPAR-g increased by a smaller order of magnitude
than did FABP4 (59,60). This pattern of expression
would correlate with FABP4 being transcriptionallyactivated by PPAR-g itself (15). Our ﬂow cytometry
ﬁndings showed lower (w6-fold) FABP4 upregula-
tion (at the protein level) by day 21, demonstrating
that mRNA levels do not directly translate into
protein levels. The correct choice of reference gene(s)
to be used when performing q-PCR is another issue
that must be taken into account when designing
protocols with the use of this technology (61).
In comparison to other methods, relatively few
studies have used ﬂow cytometry to track MSC
adipogenesis (18,20,23,24,35e37). This is sur-
prising because ﬂow cytometry provides information
on intensity of staining, size of cells, their granularity
as well as cell number. We observed a gradual
accumulation of more granular cells as the time
course progressed, correlating with increasing intra-
cellular FABP4 levels in these MSCs. Nile red dye
has previously been used in ﬂow cytometry and
microscopy to stain adipocytes derived from murine
(23,35,37,62,63) and human (18) MSCs. It is
a selective ﬂuorescent stain for intracellular lipid
droplets emitting at 528e570 nm. When Nile red
staining for lipids was assessed by ﬂow cytometry, an
increase in intracellular Nile red ﬂuorescence, similar
to FABP4 shift, was noted as the time course pro-
gressed, with more granular cells increasing in
number and gaining higher amounts of Nile red
ﬂuorescence compared with less granular cells. This
is in agreement with previous studies that demon-
strated the appearance of a new population of cells
with increased orthogonal light scattering (side
scatter) over time (64,65). We noted, however, that
low-SSC cells accumulated lipid at the same rate as
high-SSC cells, suggesting that less granular cells
were not totally “resistant” to adipogenesis. Notably,
all MSC surface markers tested failed to distinguish
between undifferentiated and adipogenically differ-
entiated MSCs or between MSCs and ﬁbroblasts, as
reported previously (39).
Our ﬁndings are in agreement with earlier studies
(64,66) and more recent studies that have used ﬂow
cytometry to sort adipocytes from mixtures of ES-
derived mesenchymal lineage cells (67). Altogether,
these data show that ﬂow cytometry is a useful tool for
tracking adipogenesis, additionally allowing the
isolation of less and more differentiated cells from the
same differentiating culture by ﬂuorescent activated
cell sorting (FACS). Because ﬂow cytometry is
a powerful multiparameter technique, gating strate-
gies using FABP4 or Nile red positivity can be further
used to discover novel surface markers of adipogeni-
cally committed cells. However, we found a loss of the
most mature, high-SSC between day 14 and day 21.
This may have been due to the increased buoyancy of
the intracellular lipid droplets in the most mature
adipocytes, causing their loss during the wash steps.
Assay validation for assessment of adipogenesis of multipotential stromal cells 99The high lipid content of these adipocytes could also
alter the strength of the cell membrane, resulting in
cells being more fragile and prone to bursting.
Therefore, a considerable disadvantage of ﬂow
cytometry is an underestimation of the proportion of
the most mature adipocytes (Table I).
Visual analysis using oil red staining showed
heterogeneity within the same adipogenesis-driven
MSC cultures, with a subset of the cells failing to
differentiate into fat cells. This is in contrast to what
was observed with the use of ﬂow cytometry, in
which gradual fat accumulation by all cells was
detected. This could be a result of the subjective
nature of the oil red grading system, which relies on
visual recognition and grading by the researcher.
The quantitative assay with the use of intracel-
lular Nile red ﬂuorescence for lipid accumulation
and DAPI staining of cell nuclei for normalization
was ﬁrst described by Jaiswal et al. (33). In our
experiments, MSCs stained with DAPI have varied
ﬂuorescence over the time course, demonstrating
that some cells continued to proliferate even when
others were differentiating at various levels. We
conﬁrmed that adipogenesis can be assessed using
a single dye (18,23,50,62,63), but, to account for
proliferation of cells, a ratio with the use of Nile red
and DAPI together was preferable. The use of a sole
Nile red dye to measure lipid content may underes-
timate or overestimate adipogenesis because there is
no compensation for proliferation or apoptosis. To
its other advantage, the ﬂuorescent microplate assay
can also provide visual veriﬁcation of adipocyte
content per cell. In all assays evaluated, ﬁbroblasts
exhibited very low levels of adipogenesis. The same
was evident for cartilage-derived cells, as previously
reported (25), and the opposite was true for fat
padederived cells, demonstrating that the Nile red
assay was robust regardless of the MSC tissue source
used.
In summary, this study explored a combination of
methods to study MSC differentiation toward adi-
pogenesis. As a result, ﬂow cytometry for FABP4 or
Nile red staining is proposed to be useful to study in
vitro differentiation of MSC cultures at the single-cell
level and potentially for the assessment of mature
adipose-lineage cell contamination in SVF prepara-
tions intended for therapy. It can also be applied to
the study of MSC maturation toward the fat tissue in
in vivo investigations, particularly in relation to
immunogenic effects associated with fat tissue
formation from implanted MSCs. The precedent for
this exists for bone neotissue, whereby its origin and
maturation status in vivo could be established after
tissue excision and enzymatic digestion followed by
ﬂow cytometry (68). In relation to a microplate assay
measuring Nile red/DAPI ratios, we propose its usefor deﬁning the cutoff point below which putative
MSC cultures are considered to lack adipogenic
potential, an important measure of MSC multi-
potentiality. At present, the International Society for
Cellular Therapy position statement deﬁning MSCs
advises qualitative assessment only of their adipo-
genesis (69), resulting in confusion as to whether
skin ﬁbroblasts or cultured chondrocytes (and other
poorly adipogenic adherent cells) can be deﬁned
as MSCs (39,70e72). A joint effort from the broader
scientiﬁc community will be required to validate the
robustness of such an assay across different research
centers.
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